1
Meta-Iodobenzylguanidine (123I-mIBG) Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease
Condition(s):Heart Failure, CongestiveLast Updated:March 14, 2018Completed
I 123 MIBG Meta Iodobenzylguanidine: 30 Clinical Trials, Page 1 of 3
Hide Studies Not Open or Pending
2
Meta-Iodobenzylguanidine Scintigraphy Imaging in Patients With Heart Failure and Control Subjects Without Cardiovascular Disease
Condition(s):Heart Failure, CongestiveLast Updated:December 13, 2016Completed
3
PET / CT With 18F-FDG: Does it Optimize the I 123-MIBG Imaging Results in the Search for Discriminating Factors for the Implementation of an Implantable Defibrillator?
Condition(s):Defibrillators, ImplantableLast Updated:February 3, 2017Terminated
4
Pathogenesis of Stress-Induced Cardiomyopathy by I-123 MIBG
Condition(s):Stress Induced CardiomyopathyLast Updated:March 22, 2016Completed
5
Autonomic Innervation and MIBG Imaging
Condition(s):Atrial FibrillationLast Updated:December 22, 2016Completed
6
Open-label, Test-retest Study Assessing Reproducibility of Quantitative Measurements of Myocardial Uptake of AdreView.
Condition(s):Heart Failure (HF); Ventricular Dysfunction, LeftLast Updated:December 8, 2016Completed
7
Meta-Iodobenzylguanidine (123I mIBG) Scintigraphy in Patients Being Evaluated for Phaeochromocytoma or Neuroblastoma
Condition(s):Pheochromocytoma; NeuroblastomaLast Updated:May 31, 2019Completed
8
123I-mIBG SPECT Imaging
Condition(s):Heart Failure; Coronary Artery DiseaseLast Updated:April 24, 2017Completed
9
Study Dosed With (123I-mIBG) for Identifying Subjects With Heart Failure Who Will Experience an Adverse Cardiac Event
Condition(s):Congestive Heart FailureLast Updated:April 26, 2017Completed
10
Phase I Study of the Safety, Distribution, and Radiation Dosimetry of Ultratrace Iobenguane 123I-mIBG
Condition(s):Neuroendocrine Tumors; Heart FailureLast Updated:November 21, 2012Completed